Cost effective analysis is the examination of the cost and the outcomes of the alternative meansof accomplishing an objective, in order to select the one among, several drugs with the highest effectiveness relative to its cost. Ceftriaxone is a third generation cephalosporin which is stable to beta-lactamases and it is highly effective against Gram negative as well as Gram positive organisms. Ceftriaxone is unique because of its prolonged serum half-life, which permits once- or twice-daily dosing of this member of Cephalosporin family. Different brands of Ceftriaxone are available in Karachi with differing costs. The present project was designed to determine the sensitivity of clinical isolates of Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi, Proteus mirabilis, Staphylococcus aureus and Klebsiella pneumoniae against different brands of ceftriaxone. Clinical isolates were collected from JPMC (Jinnah Post Medical College) and NICH (National Institute of Child Health) in Karachi. Antibacterial activity of these different brands was carried out by disk diffusion method (Kerby Bauer). All the clinical isolates showed 100% susceptibility against each brand as indicated by NCCLS (National Committee for Clinical Laboratory Standards) susceptibility limit i.e. 21 mm. Hence it is interpreted that the in-vitro activity of all brands is same despite of variation in prices which is an important factor in the total cost of therapy. Therefore, any brand with lesser price can be used conveniently for the treatment of non-affording patients.